MedPath

Alisertib

Generic Name
Alisertib
Drug Type
Small Molecule
Chemical Formula
C27H20ClFN4O4
CAS Number
1028486-01-2
Unique Ingredient Identifier
T66ES73M18

Overview

Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.

Background

Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.

Indication

For the treatment of various forms of cancer.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath